M., Satylganova, A., le Roux, C
Fine lines soften Collagen production takes time to rebuild
Senolytic Peptide FOXO4-DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes Huang Y, He Y, Makarcyzk MJ, Lin H Frontiers in Bioengineering and Biotechnology (2021) This study demonstrated that FOXO4-DRI selectively removes senescent cells from human chondrocyte cultures expanded in vitro, providing direct evidence of the peptide's senolytic activity in human cells relevant to joint and cartilage aging
doi: 10.1007/s41742-023-00539-5 121 SainiN.AnmolA.KumarS.BakshiM.DhimanZ
Meanwhile, the application of GLP-1RAs in non-diabetic diseases has also been launched
Oral tirzepatide and dosing differences The development of oral tirzepatide represents a significant evolution in how this compound can be administered